Bendroflumethiazide. Aprinox . Benzide . Benzide-M . Berkozide . Centyl . Esberizid . Naturetin . Naturine . Neo-NaClex . Pluryl . Urizid . Benzide M . Neo NaClex . Bendrofluazide . A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810) . 1.00
Benzidines. Bianilines . Biphenyldiamines . Very toxic industrial chemicals. They are absorbed through the skin, causing lethal blood, bladder, liver, and kidney damage and are potent, broad-spectrum carcinogens in most species. . 0.64
Benzydamine. Benzidamine . Benzydamine Hydrochloride . Benzydamine Monohydrochloride . Difflam . Lonol . Novo-Benzydamine . Opalgyne . PMS-Benzydamine . Ratio-Benzydamine . Rosalgin . Sun-Benz . Tantum . Tantum Topico . Hydrochloride, Benzydamine . Monohydrochloride, Benzydamine . Novo Benzydamine . PMS Benzydamine . Ratio Benzydamine . Sun Benz . Benzindamine . A benzyl-indazole having analgesic, antipyretic, and anti-inflammatory effects. It is used to reduce post-surgical and post-traumatic pain and edema and to promote healing. It is also used topically in treatment of RHEUMATIC DISEASES and INFLAMMATION of the mouth and throat. . 0.61
Benzene. Benzole . Cyclohexatriene . Benzol . Toxic, volatile, flammable liquid hydrocarbon byproduct of coal distillation. It is used as an industrial solvent in paints, varnishes, lacquer thinners, gasoline, etc. Benzene causes central nervous system damage acutely and bone marrow damage chronically and is carcinogenic. It was formerly used as parasiticide. . 0.47
Benserazide. DL-Serine 2-((2,3,4-trihydroxyphenyl)methyl)hydrazide . Ro 4-4602 . Seryltrihydroxy Benzylhydrazine . Benzylhydrazine, Seryltrihydroxy . Ro 4 4602 . Ro 44602 . Serazide . Seryltrihydroxybenzylhydrazine . An inhibitor of DOPA DECARBOXYLASE that does not enter the central nervous system. It is often given with LEVODOPA in the treatment of parkinsonism to prevent the conversion of levodopa to dopamine in the periphery, thereby increasing the amount that reaches the central nervous system and reducing the required dose. It has no antiparkinson actions when given alone. . 0.47